Provided by Tiger Trade Technology Pte. Ltd.

Actuate Therapeutics Inc

1.27
+0.04003.25%
Post-market: 1.290.0200+1.57%19:30 EDT
Volume:275.82K
Turnover:346.30K
Market Cap:30.39M
PE:-1.43
High:1.34
Open:1.22
Low:1.18
Close:1.23
52wk High:9.22
52wk Low:0.9000
Shares:23.93M
Float Shares:8.60M
Volume Ratio:0.83
T/O Rate:3.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8859
EPS(LYR):-1.0574
ROE:-553.75%
ROA:-213.40%
PB:30.72
PE(LYR):-1.20

Loading ...

Actuate Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 13

Actuate Therapeutics price target lowered to $15 from $20 at H.C. Wainwright

TIPRANKS
·
Apr 13

U.S. RESEARCH ROUNDUP-Chevron, Ford, Occidental Petroleum

Reuters
·
Apr 13

Actuate Therapeutics announces annual shareholder meeting webcast

Reuters
·
Apr 07

Top News Today/Canada: March Manufacturing PMI Slips to 50

Dow Jones
·
Apr 02

Actuate Therapeutics FY2025 operating loss narrows 10.59% to $(22.5) million; net loss narrows 18.53% to $(22.2) million

Reuters
·
Mar 27

What would a gas tax mean for ASX energy stocks?

MotleyFool
·
Mar 24

Thousands of workers could be in for a pay rise as unions push for wage liftThe push centres on award-reliant workers, who make up the bottom 23 per cent of earners in Australia.2 min read

7NEWS
·
Mar 24

Actuate Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
Mar 12

Actuate launches research initiative to combine elraglusib, RAS inhibitors

TIPRANKS
·
Mar 09

Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib With Ras Inhibitors

THOMSON REUTERS
·
Mar 09

Actuate Therapeutics Inc - Initial Data From Program Expected in Q2 2026

THOMSON REUTERS
·
Mar 09

Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors

GlobeNewswire
·
Mar 09

Actuate Therapeutics to Present at The Citizens Life Sciences Conference

GlobeNewswire
·
Mar 05

Millions of Aussies could soon get an extra week of annual leaveThe change to leave entitlements would be the biggest in half a century.3 min read

7NEWS
·
Mar 04

Actuate Therapeutics CEO Dan Schmitt to present at Oppenheimer Annual Healthcare Life Sciences Conference

Reuters
·
Feb 24